Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?
10:15am, Tuesday, 15'th Apr 2025
No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (VKTX -1.14%), the turbulence has been extremely challenging thus far. The stock is
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
11:12am, Monday, 14'th Apr 2025
Bad news for Pfizer (PFE 1.07%) turned into good news for Eli Lilly (LLY 2.42%), Novo Nordisk (NVO 2.23%), and Viking Therapeutics (VKTX 8.48%) Monday morning, each of which is rising on Pfizer's late
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
10:49am, Monday, 14'th Apr 2025
Viking Therapeutics, Inc. VKTX, Eli Lilly And Co LLY and Novo Nordisk A/S NVO stocks are trading higher on Monday.
3 Magnificent Stocks That Could Double or More by 2030
02:45pm, Saturday, 12'th Apr 2025
When the stock market is as turbulent as it is these days, it's easy to forget the times when things are decidedly more cheery. However, sell-offs present great opportunities to buy stocks with signif
Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?
05:07am, Thursday, 10'th Apr 2025
Viking Therapeutics (VKTX 15.16%) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects.
The Smartest Biotech Stocks to Buy With $50
06:15am, Thursday, 03'rd Apr 2025
One of the great things about equity markets is that you don't need a fortune to get started. Though strong companies that perform well tend to attract plenty of attention that bids up their share pri
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
04:40am, Wednesday, 02'nd Apr 2025
Viking Therapeutics (VKTX -0.99%) is operating in one of the highest-growth pharma areas around. I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply by 1
Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade
06:55pm, Tuesday, 01'st Apr 2025
In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $23.91, marking a -0.99% move from the previous day.
Which Healthcare Stock Is the Best Buy Right Now?
07:15am, Monday, 31'st Mar 2025
In the world of upstart pharmaceuticals and healthcare companies, timing is everything. These firms often struggle for an extended period of time before becoming profitable, but when they see success
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
10:30am, Thursday, 27'th Mar 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug
09:35am, Thursday, 27'th Mar 2025
Viking enrolls around 280 participants in the phase II study evaluating the oral version of its obesity drug. Data from this study is expected in 2H25.
Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study
12:43pm, Wednesday, 26'th Mar 2025
Viking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study. The post Viking Therapeutics Skids Despite 'Rapid' Enrollment
13-Week Study Evaluating the Safety and Efficacy of Oral VK2735 Dosed Once Daily Results Expected in 2H25 SAN DIEGO , March 26, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX
Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know
06:50pm, Monday, 24'th Mar 2025
In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.28, indicating a +1.14% shift from the previous trading day.
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
04:43am, Sunday, 23'rd Mar 2025
It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug market is expected to generate $12.8 billion in sales this year, and accor
